| Title: | Polyunsaturated fatty acids and diabetic microvascular complications: a Mendelian randomization study |
| Journal: | Frontiers in Endocrinology |
| Published: | 7 Aug 2024 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39170741/ |
| DOI: | https://doi.org/10.3389/fendo.2024.1406382 |
| URL: | https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1406382/pdf |
Publication 12961
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Background: Observational studies and clinical trials have implicated polyunsaturated fatty acids (PUFAs) in potentially safeguarding against diabetic microvascular complication. Nonetheless, the causal nature of these relationships remains ambiguous due to conflicting findings across studies. This research employs Mendelian randomization (MR) to assess the causal impact of PUFAs on diabetic microvascular complications.</p>
Methods: We identified instrumental variables for PUFAs, specifically omega-3 and omega-6 fatty acids, using the UK Biobank data. Outcome data regarding diabetic microvascular complications were sourced from the FinnGen Study. Our analysis covered microvascular outcomes in both type 1 and type 2 diabetes, namely diabetic neuropathy (DN), diabetic retinopathy (DR), and diabetic kidney disease (DKD). An inverse MR analysis was conducted to examine the effect of diabetic microvascular complications on PUFAs. Sensitivity analyses were performed to validate the robustness of the results. Finally, a multivariable MR (MVMR) analysis was conducted to determine whether PUFAs have a direct influence on diabetic microvascular complications.</p>
Results: The study indicates that elevated levels of genetically predicted omega-6 fatty acids substantially reduce the risk of DN in type 2 diabetes (odds ratio (OR): 0.62, 95% confidence interval (CI): 0.47-0.82, p = 0.001). A protective effect against DR in type 2 diabetes is also suggested (OR: 0.75, 95% CI: 0.62-0.92, p = 0.005). MVMR analysis confirmed the stability of these results after adjusting for potential confounding factors. No significant effects of omega-6 fatty acids were observed on DKD in type 2 diabetes or on any complications in type 1 diabetes. By contrast, omega-3 fatty acids showed no significant causal links with any of the diabetic microvascular complications assessed.</p>
Conclusions: Our MR analysis reveals a causal link between omega-6 fatty acids and certain diabetic microvascular complications in type 2 diabetes, potentially providing novel insights for further mechanistic and clinical investigations into diabetic microvascular complications.</p>
14 Keywords
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetic Angiopathies
- Diabetic Nephropathies
- Diabetic Neuropathies
- Diabetic Retinopathy
- Fatty Acids, Omega-3
- Fatty Acids, Omega-6
- Fatty Acids, Unsaturated
- Female
- Humans
- Male
- Mendelian Randomization Analysis
- Middle Aged
6 Authors
- Bingyang Liu
- Ruiyan Liu
- Yi Gu
- Xiaoying Shen
- Jianqing Zhou
- Chun Luo
Enabling scientific discoveries that improve human health